Astellas

Astellas' gastric cancer therapy gets UK regulator's nod
Reuters
Wed, 08/14/24 - 11:19 am
Astellas
UK
gastric cancer
monoclonal antibodies
Vyloy
3 Big Pharma cancer drugs facing inflation penalties
Pharma Voice
Wed, 07/31/24 - 10:27 am
inflation
Inflation Reduction Act
drug pricing
Abecma
Breyanzi
Bristol Myers Squibb
Pfizer
Adcetris
Astellas
Padcev
cancer
European Commission approves Astellas’ drug for expanded prostate cancer Treatment
Outsourcing Pharma
Thu, 04/25/24 - 05:59 pm
Astellas
Xtandi
Europe
prostate cancer
Pharmas form joint venture to jumpstart Japanese drug research
BioPharma Dive
Mon, 04/22/24 - 11:29 am
Japan
R&D
Takeda
Astellas
Sumitomo Mitsui Banking
Invenra, Astellas sign bispecific antibody discovery agreement
Pharmaceutical Business Review
Wed, 04/10/24 - 09:50 am
Astellas
Invenra
B-Body
bispecific antibodies
R&D
Bayer cues up filings for rival to Astellas’ menopause drug
Pharmaphorum
Tue, 03/19/24 - 11:35 am
Bayer
elinzanetant
menopause
hot flashes
Veozah
Astellas
Astellas puts the cork back in $350M Xork deal after Cartesian-Selecta merger
Fierce Biotech
Thu, 03/14/24 - 06:22 pm
Astellas
Cartesian Therapeutics
Xork
Pompe disease
Astellas-owned Xyphos offers more than $800M for Kelonia's in vivo delivery know-how
Fierce Biotech
Thu, 02/15/24 - 07:21 pm
Xyphos Biosciences
Astellas
Kelonia
R&D
Pharma showed up for the big game
Axios
Mon, 02/12/24 - 10:27 am
Astellas
Pfizer
Super Bowl
pharma advertising
Astellas adds digital to its top management team
Pharmaphorum
Thu, 02/8/24 - 11:05 am
Astellas
digital pharma
Astellas' sales expectations are up for Padcev, down for Veozah
Fierce Pharma
Mon, 02/5/24 - 11:02 pm
Astellas
earnings
Padcev
FDA declines to approve Astellas' gastric cancer drug
Reuters
Tue, 01/9/24 - 09:39 am
Astellas
FDA
gastric cancer
zolbetuximab
Astellas strikes $1.7bn SIRP drug deal with Elpiscience
Pharmaphorum
Tue, 01/2/24 - 09:56 am
Astellas
Elpiscience
immunotherapy
macrophages
Merck, Astellas and Pfizer bring down the house with Keytruda-Padcev FDA nod in bladder cancer
Fierce Pharma
Tue, 12/19/23 - 10:26 am
Merck
Astellas
Pfizer
Keytruda
Padcev
bladder cancer
FDA starts review of Padcev/Keytruda for bladder cancer
Pharmaphorum
Fri, 12/1/23 - 09:35 am
Merck
Astellas
Seagen
Padcev
bladder cancer
FDA
priority review
Astellas builds case for menopause drug fezolinetant
Pharmaphorum
Thu, 11/30/23 - 09:54 am
Astellas
menopause
fezolinetant
Xtandi cleared by FDA for earlier-stage prostate cancer
Pharmaphorum
Fri, 11/17/23 - 10:10 am
Pfizer
Astellas
Xtandi
prostate cancer
FDA
Astellas pays $175M for Propella, clearing early-phase rival to J&J's Zytiga for takeoff
Fierce Biotech
Thu, 11/16/23 - 11:45 am
Astellas
Propella Therapeutics
M&A
JNJ
Zytiga
prostate cancer
Astellas Sees Path Forward for Gene Therapy Despite Four Patient Deaths
BioSpace
Thu, 11/16/23 - 11:36 am
Astellas
AT132
patient deaths
FDA
X-linked myotubular myopathy
Astellas’ Izervay reduces GA lesion growth in Phase III trial
Clinical Trials Arena
Mon, 11/6/23 - 09:51 am
Astellas
Izervay
geographic atrophy
age-related macular degeneration
clinical trials

Pages